Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.tps2616
Abstract: TPS2616Background: Spartalizumab is an immunoglobulin G4 humanized monoclonal antibody that binds with subnanomolar affinity to PD-1. LAG525 is an immunoglobulin G4 humanized monoclonal antibody th...
read more here.
Keywords:
combination spartalizumab;
study combination;
lag525;
phase open ... See more keywords